Pharmacokinetic Models [Design Issues]

posted by venu  – Mumbai, India, 2007-02-14 06:00 (7060 d 06:08 ago) – Posting: # 515
Views: 5,728

Hi,

In BA/BE studies, why only 2x2 crossover design noncompartmental models are used in most of the pilot and pivotal studies? :-)

When can you use the compartmental models in the BA/BE stuides? Does the use of these compartmental models depend on the nature of the generic drugs.

Please if you could provide more information in detail regarding the questions mentioned above. :-)

Venu

Best Regards,
Ms. Vandana Panchal
Biostatistician
Mumbai
India

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
106 visitors (0 registered, 106 guests [including 12 identified bots]).
Forum time: 13:09 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me.    Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5